TABLE 1.

HK, PFK, and PK activities in clinical tumor samples

Unit	Enzyme activity			Tumor description	Refs.
	HK	PFK	PK
Units/mg of protein	0.076 ± 0.045	0.324 ± 0.158	1.94 ± 1.18	B-CLL	38
Units/mg of protein	0.006 ± 0.001	0.017 ± 0.002	0.773 ± 0.128	Malignant cervix uteri	39
Units/g of protein	30.3 ± 19.6	71.5 ± 45.5	1910 ± 2550	Uterus cervix carcinoma	40
	28.1 ± 16.1	91.4 ± 61.4	1440 ± 1040	Uterus endometrium carcinoma
Units/mg of protein	0.052 ± 0.003	0.048 ± 0.003	0.977 ± 0.079	Breast carcinomas	41
	0.032 ± 0.007	0.027 ± 0.008	0.455 ± 0.131	Intraductal carcinoma
	0.064 ± 0.006	0.053 ± 0.005	1.118 ± 0.136	Carcinoma with combined histology
	0.032 ± 0.007	0.033 ± 0.013	0.726 ± 0.256	Lobular carcinoma
Units/mg of protein	0.052 ± 0.003	0.048 ± 0.003	0.977 ± 0.079	Primary breast cancer	42
	0.083 ± 0.007	0.065 ± 0.006	1.28 ± 0.182	Metastatic breast cancer
mol/h/kg dry weight	0.46 ± 0.20	0.23 ± 0.23	0.94 ± 0.53	Malignant mammary tumor	43
Units/mg of protein	0.032 ± 0.007	\	1.54 ± 0.031	Lung tumor	44
Units/mg of protein	0.036 ± 0.023	\	1.26 ± 0.084	Neuroblastoma	45
Units/g of wet weight	1.3 ± 0.2	\	25.2 ± 4.2	Primary malignant hepatoma	46
Units/mg of protein	0.05–0.015	\	2.88–0.84	Retinoblastoma	47
Units/100 mg of tissue	0.040 ± 0.005	\	6.590 ± 0.630	Infiltrating ductal breast carcinoma	48
Units/mg of DNA	0.116 ± 0.01	\	9.84 ± 0.64	Infiltrating ductal carcinoma	49
Units/mg of protein	0.025 ± 0.003	\	0.95 ± 0.14	All human breast cancer tissues	50
	0.028 ± 0.005	\	1.23 ± 0.2	Primary breast cancer
	0.019 ± 0.003	\	0.66 ± 0.06	Metastatic breast cancer
	0.015 ± 0.004	\	0.38 ± 0.07	Chest wall
	0.010 ± 0.006	\	0.56 ± 0.06	Lung
	0.032 ± 0.018	\	1.45 ± 0.64	Lymphoma
	0.0144	\	1.24	Bone
	0.021 ± 0.010	\	0.25 ± 0.13	Brain
	0.014	\	1.24	Liver
	0.021 ± 0.006	\	0.70 ± 0.09	Lymph node